Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The GLP-1 friendly packaged food & beverage market is becoming a unique category in the wider functional and health-oriented food industry due to the growing use of GLP-1 receptor agonist medicines for managing type 2 diabetes and obesity
Zepbound (tirzepatide), a dual GIP/GLP-1 agonist, targets two hormones to boost weight loss outcomes further
The FDA approved Mounjaro for adults with type 2 diabetes
Inflammation in neurodegenerative diseases
Other meta-analyses have made stronger claims
While these side effects rarely impact cardiovascular health directly, discomfort during treatment may influence patient adherence
US$ 22.83
US$ 29.42
US$ 21.83
US$ 28.70
US$ 23.72
US$ 20.68
US$ 21.25
US$ 25.05
